Results 141 to 150 of about 24,552 (280)
Development of a Model for Chemical Screening Based on Collateral Sensitivity to Target BTK C481S Mutant [PDF]
, 2020 Camille Libre +10 more
openalex +1 more source
Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibition [PDF]
, 2020 Pavan Bhargava +9 more
openalex +1 more source
CDK9 pharmacological inhibition with PRT2527 has antitumor activity in marginal zone lymphoma models and can improve the effects of BTK, PI3K, and BCL2 inhibitors [PDF]
Eleonora Cannas +8 more
openalex +1 more source
Clinical Breakthrough in Targeted Protein Degradation: Reflections on the Approval of ARV‐471
Cancer Innovation, Volume 5, Issue 3, June 2026.
Yu Rao
wiley +1 more source
Vascular Calcification: Mechanisms, Models, and Therapies
iNew Medicine, Volume 2, Issue 2, June 2026.ABSTRACT Vascular calcification represents an active multifactorial process that mirrors several key features of skeletal bone mineralization. Clinically, it is characterized by diminished arterial compliance and increased arterial wall stiffness, both of which serve as independent predictors of significant adverse cardiovascular events.
Wenya Zhu +5 more
wiley +1 more source
Novel BTK inhibitors and degraders for relapsed/refractory CLL/SLL: latest updates from ASH 2025 annual meeting. [PDF]
J Hematol OncolSharma P, Jiang H, Liu D.
europepmc +1 more source